best glp-1 drug 2025 therapies are changing obesity care. What does WHO recommend? Here's what you need to know Comparing Ozempic, Wegovy and Other

[DOI] [PubMed] [Google Scholar] 56.Niemel O

Sep 2009;139(9):1806S-1812S

The Ozempic prescribing information directs clinicians to start at 0.25 mg once weekly for 4 weeks (tolerance-building), then increase to 0.5 mg, and if needed to 1 mg and 2 mg after at least 4 weeks at each level, using patient response and side-effect history to guide the ramp

Nevertheless, the evidence points in the same direction as for Wegovy: Despite offering robust clinical benefits, in the short-term both products are not cost-saving due mainly to their high cost

Furthermore, the extract demonstrated a positive impact on lens homeostasis, as evidenced by increased glutathione levels and the maintenance of crucial lens proteins

Additionally, GLP-1 agonists may modulate the renin-angiotensin-aldosterone system (RAAS), further influencing vascular tone and blood pressure regulation (54)